Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
$1.86B |
| 2 |
Exxon Mobil
XOM
|
$1.35B |
| 3 |
Apple
AAPL
|
$1.19B |
| 4 |
NVIDIA
NVDA
|
$1.18B |
| 5 |
Amazon
AMZN
|
$1.06B |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
$1.24B |
| 2 |
GE Aerospace
GE
|
$712M |
| 3 |
Broadcom
AVGO
|
$499M |
| 4 |
Apollo Global Management
APO
|
$286M |
| 5 |
Super Micro Computer
SMCI
|
$243M |
Sector Composition
| 1 | Technology | 31.9% |
| 2 | Financials | 12.27% |
| 3 | Healthcare | 11.66% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Communication Services | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3776
Rallybio
RLYB
$25.4M
| $295K | ﹤0.01% |
220,006
-299,642
| -58% | -$402K |
|
3777
Elicio Therapeutics
ELTX
$188M
| $294K | ﹤0.01% |
71,508
+23,812
| +50% | +$97.9K |
|
3778
Capital Southwest
CSWC
$1.28B
| $294K | ﹤0.01% |
11,251
| – | – |
|
3779
WidePoint Corp
WYY
$49.2M
| $293K | ﹤0.01% |
70,018
+13,035
| +23% | +$54.6K |
|
3780
Armata Pharmaceuticals
ARMP
$103M
| $293K | ﹤0.01% |
106,489
+6,601
| +7% | +$18.2K |
|
3781
Acurx Pharmaceuticals
ACXP
$6.47M
| $293K | ﹤0.01% |
6,501
+683
| +12% | +$30.7K |
|
3782
Protara Therapeutics
TARA
$122M
| $292K | ﹤0.01% |
140,526
+57,619
| +69% | +$120K |
|
3783
Knightscope
KSCP
$55.8M
| $290K | ﹤0.01% |
18,886
+4,553
| +32% | +$69.9K |
|
|
FLNT
3784
Fluent
FLNT
$53.1M
| $289K | ﹤0.01% |
80,066
+5,380
| +7% | +$19.4K |
|
3785
Perion Network
PERI
$413M
| $289K | ﹤0.01% |
34,552
| – | – |
|
3786
Immuneering
IMRX
$229M
| $284K | ﹤0.01% |
221,801
-240,719
| -52% | -$308K |
|
3787
Optex Systems
OPXS
$80M
| $282K | ﹤0.01% |
39,063
+4,939
| +14% | +$35.7K |
|
3788
Immix Biopharma
IMMX
$62M
| $281K | ﹤0.01% |
142,128
+17,358
| +14% | +$34.4K |
|
|
SGMA
3789
DELISTED
Sigmatron International
SGMA
| $280K | ﹤0.01% |
50,116
+2,369
| +5% | +$13.2K |
|
3790
GEE Group
JOB
$20.8M
| $280K | ﹤0.01% |
912,912
+7,148
| +0.8% | +$2.19K |
|
3791
NSTS Bancorp
NSTS
$62.7M
| $280K | ﹤0.01% |
29,054
-2,492
| -8% | -$24K |
|
|
OPRA
3792
Opera Ltd
OPRA
$1.6B
| $280K | ﹤0.01% |
19,937
-2,172
| -10% | -$30.5K |
|
3793
Bogota Financial
BSBK
$119M
| $279K | ﹤0.01% |
41,519
+2,307
| +6% | +$15.5K |
|
3794
IRIDEX
IRIX
$23.8M
| $279K | ﹤0.01% |
129,092
+8,398
| +7% | +$18.1K |
|
|
OBE
3795
Obsidian Energy
OBE
$392M
| $279K | ﹤0.01% |
37,259
-415
| -1% | -$3.11K |
|
3796
Bolt Biotherapeutics
BOLT
$9.96M
| $278K | ﹤0.01% |
18,540
+1,162
| +7% | +$17.4K |
|
|
CRESY
3797
Cresud
CRESY
$589M
| $278K | ﹤0.01% |
33,826
| – | – |
|
3798
Catalyst Bancorp
CLST
$54.2M
| $278K | ﹤0.01% |
23,966
-15,421
| -39% | -$179K |
|
3799
Nine Energy Service
NINE
$28.5M
| $278K | ﹤0.01% |
165,207
| – | – |
|
3800
Jin Medical International
ZJYL
$97M
| $277K | ﹤0.01% |
106,540
| – | – |
|